Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).-论文-万方医学网

第一作者： Christopher P,Venner

第一单位： The Vancouver Hospital and Health Science Center, British Columbia, Canada.

作者： Christopher P,Venner ^[1] ; Joseph M,Connors ; Heather J,Sutherland ; John D,Shepherd ; Linda,Hamata ; Yasser Abou,Mourad ; Michael J,Barnett ; Raewyn,Broady ; Donna L,Forrest ; Donna E,Hogge ; Stephen H,Nantel ; Sujaatha,Narayanan ; Thomas J,Nevill ; Janet,Nitta ; Maryse M,Power ; Cynthia L,Toze ; Clayton A,Smith ; Kevin W,Song

作者单位： The Vancouver Hospital and Health Science Center, British Columbia, Canada. ^[1]

主题词成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);硼酸化物(Boronic Acids);综合疗法(Combined Modality Therapy);女(雌)性(Female);随访研究(Follow-Up Studies);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);肿瘤复发, 局部(Neoplasm Recurrence, Local);预后(Prognosis);吡嗪类(Pyrazines);危险因素(Risk Factors);存活率(Survival Rate);沙立度胺(Thalidomide);移植, 自体(Transplantation, Autologous);青年人(Young Adult)

DOI 10.3109/10428194.2010.531409

PMID 21133716

发布时间 2019-01-16

检索历史清除

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).

Leukemia & lymphoma

相似文献

Leukemia & lymphoma

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (&lt;12 months).

Leukemia & lymphoma

相似文献

Leukemia & lymphoma

相关期刊

检索历史清除

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).